DAFTAR PUSTAKA

Ansel HC. 1985. Pengantar Bentuk Sediaan Farmasi. UI Press :Jakarta.

Bethlehem. (2011). Biopharmaceutical Classification System and Formulation
Development. Technical Brief 2011 Volume 9.
Gunawi, Ratih H., Dhadhang W. K., dan Vitis V.F.R.U., 2009, Peningkatan Laju
DisolusiTablet Piroksikam menggunakan Polisorbat 80, Vol.1, No.1, Jawa
Tengah.
Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain
AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. 2004.
Molecular properties of WHO essential drugs and provisional
biopharmaceutical classification. Mol Pharm 1:8596.
Reddy, Kumar., & Karunakar. (2011). Biopharmaceutics Classification System: A
Regulatory Approach. Dissolution Technologies, 31-37.
Shohin IE, Kulinich JI, Raamenskaya GV, Abrahamsson B, Kopp S, Langguth P,
Polli JE, Shah VP, Groot DW, Barends DM, Dressman JB. 2014. Biowaiver
Monographs for Immediate Release Solid Oral Dosage Forms: Piroxicam.
Journal of Pharmaceutical Sciences 103:367377
Sutriyo., Rachmat, Hasan., & Rosalina, Mita. (2007). Pengembangan Sediaan dengan
Pelepasan Dimodifikasi Mengandung Furosemid sebagai Model zat aktif
Menggunakan Sistem Mukoadhesif. Majalah Ilmu Kefarmasian, 5(1), 1-8.
World Health Organization (WHO). 2006. Proposal to waive in vivo bioequivalence
requirements for WHO Model List of Essential Medicines immediate-release,
solid oral dosage forms. Technical Re- port Series, No 937, 40th Report,
Annex.8 of WHO Expert Committee on Specifications for Pharmaceutical
Preparations. Accessed November 1, 2010, Available online at:
http://whqlibdoc.who.int/trs/WHO TRS 937 eng.pdf [diakses 27 September
2014]
Wagh P., Millind., & Patel, Jatis. (2010). Biopharmaceutical Classification System:
Scientific Basis for Biowaiver Extensions. International Journal of Pharmacy
and Pharmaceutical sciences, 2(1), 12-19.